Aprepitant Regimen Sustains Antiemetic Effect Over Multiple Chemotherapy Cycles
Tuesday, 23 March 2004
NEW YORK (Reuters Health) - The addition of the drug aprepitant to other antiemetic therapy is associated with less nausea and vomiting during an initial cycle of chemotherapy, and the response is maintained well during subsequent cycles, investigators report.
read more
|
Excess Mortality Risk Increases Over Time in Seminoma Survivors
Thursday, 11 March 2004
NEW YORK (Reuters Health) - The risk of death from heart disease or second cancer rises significantly above that of the general population 15 years after treatment for testicular seminoma with orchiectomy and radiation therapy, report physicians at the University of Texas M.D. Anderson Cancer Center in Houston.
read more
|
Alternative Therapies Popular with Cancer Patients
Tuesday, 24 February 2004
NEW YORK (Reuters Health) - Insured cancer patients in the State of Washington are considerably more likely to use complementary and alternative medical providers than are insured patients without the disease, researchers report in the February 23rd online edition of Cancer.
read more
|
Careful Open Resection of Genital Branch of Genito-Femoral Nerve Relieves Chronic Post-herniorrophy Testicular Pain
Monday, 16 February 2004
Chronic scrotal and testicular pain represent objectionable side effects of inguinal herniorrophy surgery.
read more
|
Cancer Web Sites No Aid to Trial Enrollment
Tuesday, 10 February 2004
NEW YORK (Reuters Health) - Web sites for organizations involved in clinical cancer research lack sufficient information to enhance patient enrollment in clinical trials, according to a report in the February 9th online edition of Cancer.
read more
|
Long-Term Survival After High-Dose Salvage Chemotherapy for Germ Cell Malignancies with Adverse Prognostic Variables
Monday, 02 February 2004
BERKELEY, CA (UroToday Inc.) - Testis cancer remains the paradigm of success in the treatment of solid malignancies. Approximately 70% of patients with metastatic testicular cancer are cured with their initial cisplatin-based combination chemotherapy. However, 30% of patients fail and will require salvage therapy.
read more
|
Review of Clinical Outcome After RPLND in Patients with Pure Testicular Teratoma Underscores the Metastatic Potential of Teratoma
Monday, 26 January 2004
Teratomatous elements occur in 55-79% of primary testicular nonseminomatous germ cell tumors (NSGCT) with pure teratoma comprising 2-6% of cases. Given the rarity of this latter histologic finding in adults with NSGCT, controversy exists in published reports regarding the most appropriate management of the retroperitoneum after radical orchiectomy.
read more
|
Organ-sparing Approach Seems Safe for Small Testicular Tumors
Monday, 29 September 2003
NEW YORK (Reuters Health) - A strategy involving the intraoperative assessment of frozen tumor sections appears to be a useful organ-sparing alternative to orchiectomy for testicular tumors, new research shows.
read more
|
Early Environmental Exposures Related to Risk of Testicular Cancer: Study
Monday, 01 September 2003
NEW YORK (Reuters Health) - The risk of testicular cancer is determined in large part by environmental exposure early in life, suggest the results of a study published in the August 20th issue of the Journal of the National Cancer Institute.
read more
|
Testicular Cancer Survivors "Surprisingly" Active
Tuesday, 01 July 2003
NEW YORK (Reuters Health) - Results of a study published in the June issue of the European Journal of Cancer suggest that the level of physical activity is increased rather than decreased in long-term survivors of testicular cancer.
read more
|
HIV-Infected Men Face Higher Risk of Testicular Seminoma
Tuesday, 10 June 2003
NEW YORK (Reuters Health) - HIV-infected men face a significantly higher risk of testicular seminoma than do age-matched HIV-negative men, according to a report in the May 15th Journal of Clinical Oncology.
read more
|
Heart Disease Risk Increased After Testicular Cancer Treatment
Wednesday, 14 May 2003
NEW YORK (Reuters Health) - Evidence continues to mount that long-term survivors of testicular cancer who are treated with chemotherapy or radiotherapy are at significantly increased risk of cardiovascular disease.
read more
|
Testicular Cancer Risk with Cryptorchism Clears with Prepubertal Orchiopexy
Tuesday, 15 April 2003
NEW YORK (Reuters Health) - For boys with cryptorchism, orchiopexy before age 11 offers the best protection against testicular cancer, according to a report in the April 1st American Journal of Epidemiology.
read more
|
Testicular Self-examination: Education of Residents and Patients Lacking
Tuesday, 04 March 2003
NEW YORK (Reuters Health - Most adolescent and young adult men are unaware of their risk for testicular cancer and do not know how to perform testicular self-examination (TSE). Futhermore, many physicians have never been taught how to perform TSE and therefore can not teach it to their patients.
read more
|
Gene Linked to Testicular Cancer and Sterility
Thursday, 06 June 2002
NEW YORK (Reuters Health) - Overexpression of a recently characterized gene called "hiwi" is associated with the development of seminomas in men, according to a new report. Interestingly, findings from another study by the same research team suggest that underexpression of the gene may cause sterility.
read more
|
UK Men Reluctant to Discuss Prostate and Testicular Cancer
Friday, 31 May 2002
LONDON (Reuters) - British men often view prostate and testicular cancer as a threat to their masculinity and shy away from finding out about the diseases, sometimes with tragic results, Cancer Research UK said on Friday.
read more
|
Postmortem Diagnosis Highlights Importance of Testicular Self-examination
Friday, 10 May 2002
NEW YORK (Reuters Health) - A case report of the death of a 17-year-old man from a massive pulmonary embolism, probably caused by metastatic testicular carcinoma invading the inferior vena cava, reinforces the need for early diagnosis and treatment of testicular cancer, Dutch researchers report in the May 11th issue of The Lancet.
read more
|
Mortality After Cure of Testicular Cancer
-
BERKELEY, CA (UroToday Inc.) - Testicular seminoma presents at a relatively early phase in its natural history. Thus, today >95% of all men with this disease are cured.
read more
|
Testing for Tumor Protein in Semen Samples Detects Early Testicular Cancer
-
NEW YORK (Reuters Health) - Findings from a case report suggest that testicular cancer can be diagnosed at an early, more treatable stage by testing semen samples for a neoplastic marker.
read more
|
Testicular Cancer 
